会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • Therapeutic agents—I
    • 治疗剂 - I
    • US07449492B2
    • 2008-11-11
    • US10315288
    • 2002-12-09
    • James Harrison AylwardPeter Gordon ParsonsAndreas SuhrbierKathleen Anne Turner
    • James Harrison AylwardPeter Gordon ParsonsAndreas SuhrbierKathleen Anne Turner
    • A61K31/21
    • A61K31/455A61K31/22A61K36/47C07C69/533Y02A50/401Y02A50/402Y02A50/409Y02A50/414Y02A50/415Y02A50/463Y02A50/465Y02A50/469Y02A50/471Y02A50/473Y02A50/475Y02A50/478Y02A50/481Y02A50/483Y02A50/491Y02A90/26
    • The present invention relates generally to chemical agents useful in the treatment and prophylaxis of infection by pathogenic or potentially pathogenic entities, or entities capable of opportunistic infection in mammals, including humans and primates, non-mammalian animals and avian species. More particularly, the present invention provides a chemical agent of the macrocyclic diterpene family obtainable from a member of the Euphorbiaceae family of plants or botanical or horticultural relatives thereof or derivatives or chemical analogues or chemically synthetic forms of the agents for use in the treatment or prophylaxis of infection by pathogenic entities in mammalian, animal and avian subjects. The present invention further contemplates a method for the prophylaxis and/or treatment in mammalian, animal or avian subjects of infection or potential infection by pathogenic entities by the topical or systemic administration of a macrocyclic diterpene obtainable from a member of the Euphorbiaceae family of plants or their botanical or horticultural derivatives or a derivative, chemical analogue or chemically synthetic form of the agent. The chemical agent of the present invention may be in the form of a purified compound, mixture of compounds, a precursor form of one or more of the compounds capable of chemical transformation into a therapeutically active agent or in the form of a chemical fraction, sub-fraction, preparation or extract of the plant.
    • 本发明一般涉及用于治疗和预防致病或潜在致病实体或能够在包括人和灵长类动物,非哺乳动物和禽类物种在内的哺乳动物中机会感染的实体的感染的化学试剂。 更具体地说,本发明提供了一种可从植物或植物或园艺亲属的大戟科家族成员获得的大环二萜类化合物或用于治疗或预防的药剂的衍生物或化学类似物或化学合成形式 在哺乳动物,动物和禽类受试者中感染病原体。 本发明进一步考虑了一种通过局部或全身施用可从植物大戟科植物的成员获得的大环二萜在哺乳动物,动物或禽类受试者中预防和/或治疗感染或潜在感染的方法,或 其植物或园艺衍生物或衍生物,化学类似物或化学合成形式的药剂。 本发明的化学试剂可以是纯化合物的形式,化合物的混合物,能够化学转化成治疗活性剂或以化学级分形式的一种或多种化合物的前体形式 - 植物的分离,制备或提取。
    • 3. 发明申请
    • MACROCYCLIC DITERPENES FOR TREATING CONDITIONS ASSOCIATED WITH PROTEIN KINASE C
    • 用于处理与蛋白激酶C相关的条件的大分子化合物
    • US20110213002A1
    • 2011-09-01
    • US13034172
    • 2011-02-24
    • James Harrison AylwardPeter Gordon ParsonsAndreas SuhrbierKathleen Anne Turner
    • James Harrison AylwardPeter Gordon ParsonsAndreas SuhrbierKathleen Anne Turner
    • A61K31/465A61K31/22A61P11/06A61P9/00A61P7/00A61P25/28A61P25/24A61P3/10A61P25/00A61P19/00A61P31/12A61P17/06A61K31/122
    • A61K31/455A61K31/22A61K36/47C07C69/533Y02A50/401Y02A50/402Y02A50/409Y02A50/414Y02A50/415Y02A50/463Y02A50/465Y02A50/469Y02A50/471Y02A50/473Y02A50/475Y02A50/478Y02A50/481Y02A50/483Y02A50/491Y02A90/26
    • The present invention relates generally to chemical agents useful in the treatment and prophylaxis of inflammatory conditions or in the amelioration of symptoms resulting from or facilitated by an inflammatory condition in a mammalian animal including human and primate, non-mammalian animal and avian species. More particularly, the present invention provides a chemical agent of the macrocyclic diterpene family obtaining from a member of the Euphorbiaceae family of plants or botanical or horticultural relatives thereof or derivatives or chemical analogues or chemically synthetic forms of the agents for use in the treatment or prophylaxis of an inflammatory condition or in the amelioration of symptoms resulting from or facilitated by an inflammatory condition in a mammal, animal or avian species. The present invention further contemplates a method for the prophylaxis or treatment of mammalian, animal or avian subjects for inflammatory conditions including chronic or transitory inflammatory conditions or for ameliorating the symptoms of an inflammatory condition by the topical or systemic administration of a macrocyclic diterpene obtainable from a member of the Euphorbiaceae family or botanical or horticultural relatives thereof or a derivative, chemical analogue or chemically synthetic form of the agent. The chemical agent of the present invention may be in the form of a purified compound, mixture of compounds, a precursor form of one or more of the compounds capable of chemical transformation into a therapeutically active agent or be in the form of a chemical fraction, sub-fraction or preparation or extract of the plant.
    • 本发明一般涉及用于治疗和预防炎性病症或改善由哺乳动物(包括人类和灵长类,非哺乳动物和禽类)物种中的炎性病症引起或促进的症状的化学试剂。 更具体地说,本发明提供从大戟科植物或植物或园艺亲属的成员获得的大环二萜类家族化学试剂或用于治疗或预防的药剂的衍生物或化学类似物或化学合成形式 的炎性病症或改善由哺乳动物,动物或禽类物种中的炎性病症引起或促进的症状。 本发明进一步考虑了一种用于预防或治疗哺乳动物,动物或禽类受试者的炎症性疾病的方法,包括慢性或短暂性炎性病症或通过局部或全身给予大环二萜来改善炎症状态的症状,所述大环二萜可从 大戟科的成员或植物或园艺亲属或衍生物,化学类似物或化学合成形式的药剂。 本发明的化学试剂可以是纯化的化合物,化合物的混合物,能够化学转化成治疗活性剂或以化学级分形式的一种或多种化合物的前体形式, 子部分或植物的制备或提取物。
    • 5. 发明申请
    • MACROCYCLIC DITERPENES FOR TREATING CONDITIONS ASSOCIATED WITH PROTEIN KINASE C
    • 用于处理与蛋白激酶C相关的条件的大分子化合物
    • US20100048698A1
    • 2010-02-25
    • US12543087
    • 2009-08-18
    • James Harrison AylwardPeter Gordon ParsonsAndreas SuhrbierKathleen Anne Turner
    • James Harrison AylwardPeter Gordon ParsonsAndreas SuhrbierKathleen Anne Turner
    • A61K31/215A61P29/00
    • A61K31/455A61K31/22A61K36/47C07C69/533Y02A50/401Y02A50/402Y02A50/409Y02A50/414Y02A50/415Y02A50/463Y02A50/465Y02A50/469Y02A50/471Y02A50/473Y02A50/475Y02A50/478Y02A50/483Y02A50/491Y02A90/26
    • The present invention relates generally to chemical agents useful in the treatment and prophylaxis of inflammatory conditions or in the amelioration of symptoms resulting from or facilitated by an inflammatory condition in a mammalian animal including human and primate, non-mammalian animal and avian species. More particularly, the present invention provides a chemical agent of the macrocyclic diterpene family obtaining from a member of the Euphorbiaceae family of plants or botanical or horticultural relatives thereof or derivatives or chemical analogues or chemically synthetic forms of the agents for use in the treatment or prophylaxis of an inflammatory condition or in the amelioration of symptoms resulting from or facilitated by an inflammatory condition in a mammal, animal or avian species. The present invention further contemplates a method for the prophylaxis or treatment of mammalian, animal or avian subjects for inflammatory conditions including chronic or transitory inflammatory conditions or for ameliorating the symptoms of an inflammatory condition by the topical or systemic administration of a macrocyclic diterpene obtainable from a member of the Fuphorbiaceae family or botanical or horticultural relatives thereof or a derivative, chemical analogue or chemically synthetic form of the agent. The chemical agent of the present invention may be in the form of a purified compound, mixture of compounds, a precursor form of one or more of the compounds capable of chemical transformation into a therapeutically active agent or be in the form of a chemical fraction, sub-fraction or preparation or extract of the plant.
    • 本发明一般涉及用于治疗和预防炎性病症或改善由哺乳动物(包括人类和灵长类,非哺乳动物和禽类)物种中的炎性病症引起或促进的症状的化学试剂。 更具体地说,本发明提供从大戟科植物或植物或园艺亲属的成员获得的大环二萜类家族化学试剂或用于治疗或预防的药剂的衍生物或化学类似物或化学合成形式 的炎性病症或改善由哺乳动物,动物或禽类物种中的炎性病症引起或促进的症状。 本发明进一步考虑了一种用于预防或治疗哺乳动物,动物或禽类受试者的炎症性疾病的方法,包括慢性或短暂性炎性病症或通过局部或全身给予大环二萜来改善炎症状态的症状,所述大环二萜可从 大戟科(Fuphorbiaceae)家族的成员或其植物或园艺亲属,或代理人的衍生,化学类似物或化学合成形式。 本发明的化学试剂可以是纯化的化合物,化合物的混合物,能够化学转化成治疗活性剂或以化学级分形式的一种或多种化合物的前体形式, 子部分或植物的制备或提取物。
    • 10. 发明授权
    • Anti-cancer compounds
    • 抗癌化合物
    • US07410656B2
    • 2008-08-12
    • US10896811
    • 2004-07-22
    • James Harrison Aylward
    • James Harrison Aylward
    • A61K36/00A61K31/12A61K31/045
    • A61K36/47A61K31/225A61K2300/00
    • This invention relates to a compound or group of compounds present in an active principle derived from plants of species Euphorbia peplus, Euphorbia hirta and Euphorbia drummondii, and to pharmaceutical compositions comprising these compounds. Extracts from these plants have been found to show selective cytotoxicity against several different cancer cell lines. The compounds are useful in effective treatment of cancers, particularly malignant melanomas and squamous cell carcinomas (SCCs). In a preferred embodiment of the invention, the compound is selected from the group consisting of jatrophanes, pepluanes, paralianes and ingenanes, andpharmaceutically-acceptable salts or esters thereof, and more particularly jatrophanes of Conformation II.
    • 本发明涉及存在于源自大戟属植物,大戟属和大戟属植物的活性成分中的化合物或一组化合物,以及包含这些化合物的药物组合物。 已经发现这些植物的提取物显示出对几种不同癌细胞系的选择性细胞毒性。 该化合物可有效治疗癌症,特别是恶性黑素瘤和鳞状细胞癌(SCC)。 在本发明的一个优选实施方案中,该化合物选自由琼脂糖,胡椒酰,对氨基苯甲酸和嵌合物组成的组,及其药学上可接受的盐或酯,更特别是构象II的麻风病毒。